SB 146 — Fetal and Infant Mortality Reduction

Summary

Fetal and Infant Mortality Reduction; Revising the purpose and requirements for the Comprehensive Statewide Tobacco Education and Use Prevention Program; requiring the Department of Health to contract with local healthy start coalitions for the creation of fetal and infant mortality review committees in all regions of this state; prohibiting a physician from performing a termination of pregnancy if the physician determines the gestational age of a fetus is more than a specified number of weeks, with exceptions; requiring the directors of certain medical facilities and certain physicians to submit a certain report to the Agency for Health Care Administration monthly, etc. APPROPRIATION: $260,000

Bill Text

• Introduced S 146 Filed Current pdf

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill amends existing law to create fetal and infant mortality review committees and revise provisions related to tobacco prevention and reporting requirements.

• 381.84

  It is the purpose of this section to implement s. 27, Art. X of the State Constitution. → It is the purpose of this section to implement s. 27, Art. X of the State Constitution.

  The purpose statement remains the same.

• 381.84

  The Legislature finds that s. 27, Art. X of the State Constitution requires the funding of a statewide tobacco education and use prevention program that focuses on tobacco use by youth. → The Legislature finds that s. 27, Art. X of the State Constitution requires the funding of a statewide tobacco education and use prevention program that focuses on tobacco use by youth.

  The finding regarding the funding of tobacco prevention remains unchanged.

• 381.84

  The primary goals of the program are to reduce the prevalence of tobacco use among youth, adults, and pregnant women, and women who may become pregnant; reduce per capita tobacco consumption; and reduce exposure to environmental tobacco smoke. → The primary goals of the program are to reduce the prevalence of tobacco use among youth, adults, and pregnant women, and women who may become pregnant; reduce per capita tobacco consumption; and reduce exposure to environmental tobacco smoke.

  The goals outlined for the tobacco program remain unchanged.

• 381.84

  Further, it is the intent of the Legislature to base increases in funding for individual components of the program on the results of assessments and evaluations. → Further, it is the intent of the Legislature to base increases in funding for individual components of the program on the results of assessments and evaluations.

  The legislative intent regarding funding increases remains the same.

• 381.84

  By January 31 of each year, the department shall provide to the Governor, the President of the Senate, and the Speaker of the House of Representatives a report that evaluates the program’s effectiveness in reducing and preventing tobacco use and that recommends improvements to enhance the program’s effectiveness. → By January 31 of each year, the department shall provide to the Governor, the President of the Senate, and the Speaker of the House of Representatives a report that evaluates the program’s effectiveness in reducing and preventing tobacco use and that recommends improvements to enhance the program’s effectiveness.

  The requirement for the annual report to evaluate the tobacco program remains intact.

• 383.21625

  Fetal and infant mortality review committees.

  The bill establishes fetal and infant mortality review committees to analyze and reduce mortality rates.

• 383.21625

  The department shall contract with local healthy start coalitions for the creation of fetal and infant mortality review committees in all regions of this state to reduce the incidence of fetal and infant mortality and morbidity in each region.

  It requires the Department of Health to establish local committees aimed at reviewing and addressing fetal and infant mortality.

• 383.21625

  Each committee shall: Review and analyze rates, trends, causes, and other data related to fetal and infant mortality and morbidity in its geographic area.

  Committees are tasked with reviewing data related to fetal and infant mortality.

• 383.21625

  Develop findings and recommendations for interventions and policy changes to reduce fetal and infant mortality and morbidity rates.

  Committees will create recommendations for policies aimed at reducing mortality rates.

• 383.21625

  Engage with local communities and stakeholders to implement recommended policies and procedures to reduce fetal and infant mortality and morbidity.

  Committees are required to engage with local stakeholders to implement policies.

Action History

1. March 14, 2022

   Died in Appropriations, companion bill(s) passed, see CS/HB 5 (Ch. 2022-69)

2. March 12, 2022

   Indefinitely postponed and withdrawn from consideration

3. February 02, 2022

   Now in Appropriations

4. February 02, 2022

   Favorable by Health Policy; YEAS 6 NAYS 4

5. January 28, 2022

   On Committee agenda-- Health Policy, 02/02/22, 11:00 am, 412 Knott Building

6. January 18, 2022

   Introduced

7. January 12, 2022

   Referred to Health Policy; Appropriations

8. January 11, 2022

   Filed

Sponsors

• Stargel · Primary
• Rodrigues · Cosponsor
• Danny Burgess · Cosponsor
• Joe Gruters · Cosponsor
• Jennifer Bradley · Cosponsor

Votes

Subjects